Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Cancer Prev Res (Phila). 2019 Mar 1;12(4):271–282. doi: 10.1158/1940-6207.CAPR-18-0435

Table 4.

Perceptions of Modality-Specific Regimen, Possible Side Effects and Effectiveness

Modality-Specific Factors of Willingness to Use Chemopreventive Agents
Modality Perceptions of Regimen Perceptions of Side Effects Perceptions of Effectiveness
Pill
(for breast/ovarian cancers)
- Noted ease and convenience of being able to fit into and/or combine with existing daily routines (e.g., brushing teeth, taking birth control pill)
- Expressed uncertainty in their ability to carry out a daily pill regimen for 5 years
- Concerned about impact of missing a dose
- Expressed most concern for increased risk of uterine cancer and blood clots – perceived as too serious for preventive purposes - Considered pills not as effective as modalities that delivered medicine directly to the organ(s) of concern
- Perceived risk-reduction activities, such as diet and exercise, to be more effective
Topical Agent – Gel/Cream
(for all cancers)
- Perceived as easy and convenient
- Expressed confidence in being able to fit it into their existing daily routines (e.g., beauty/skin care regimen) indefinitely
- Preferred regimen that didn’t require application outside the home
- Wanted to know more about the application process, such as whether they could take a shower after applying or if re-application would be necessary after exercise or sweating
- Concerned about the severity and duration of the irritated skin and rash
- Worried about an unpleasant application process or impact on their skin (e.g., messy application process, leaves a sticky residue, dries out their skin, skin smells during/after application, stains clothing)
- Noted that sensitivity to light was not a problem as long as they could still enjoy activities outside
- Concerned for others that may come in contact with topical agent (e.g., intimate encounters with partner, child sleeping on their chest)
- Skeptical of how a gel/cream could be effective at preventing cancer without serious side effects, such as interfering with hormones
Topical Agent – Mouthwash
(for head/neck/oral cancers)
- Perceived as simple and convenient
- Cited ease in being able to fit into and/or combine with existing daily routines (e.g., brushing teeth)
- Expressed confidence in being able to adhere to regimen indefinitely
- Felt that swishing and/or rinsing was less invasive than swallowing
-Worried about how the rash would impact their ability to breathe, communicate, and eat
- Apprehensive about taste (e.g., leaves a bad taste in mouth, gag reflex effect)
- Concerned about the severity and duration of the irritated skin or rash, and if it would have a “domino effect” leading to sores or blisters, and possibly infections
- Skeptical of how a mouthwash could be effective at preventing cancer
Hormonal Implant or Ring
(for gynecologic cancers)
- Unwillingness stemmed from negative experiences with birth control (e.g., intrauterine device, vaginal ring)
- Concerned about invasive nature of the modality, citing their fear of having a foreign object inside their body
- Expressed comfort in having a doctor involved to properly insert the device
- Apprehensive about taking the power and/or control out of their hands
- Concerned about increasing side effects already experienced through menstruation, birth control, or other gynecologic conditions (e.g., PCOS)
- Disliked the possibility of weight gain
- Alarmed about the possibility of ovarian cysts and hormones’ impact on fertility, pregnancy, and breastfeeding
- Considered more effective because a healthcare provider inserts the device
Aerosolized Drug
(for lung cancer)
- Felt comfortable using due to prior experience and/or familiarity with an inhaler (e.g., asthma, allergies)
- Noted the convenience factor of being able to carry it with you
- Hesitant (more so average-risk participants) to carry small aerosolized drug device
- Preferred frequency of use varied greatly
- High-risk participants expressed willingness to increase frequency of use for a shorter duration of time (e.g., daily use for 30 days) or indefinite use
- Perceived to have fewer side effects (compared to a pill)
- Concerned about severity and duration of cough (e.g., impact on sleeping, interference at work)
- Some high-risk participants familiar with coughing due to smoking and COPD were worried about increased coughing
- Other participants were unconcerned and considered it mild in the context of cancer
- Considered more effective due to local delivery and minimal impact on other organ systems
Light Stimulation Therapy
(for head/neck/oral cancers)
- Liked the convenience of a one-time treatment
- Concerned about accessibility to a clinic
- Expressed comfort in knowing a healthcare provider would be involved
- Unconcerned about need to take a pill along with the light therapy
- Wanted to know more about the regimen (e.g., length of session) and type of light being used
- Concerned about “long laundry list” of possible side effects
- Alarmed about possible burning and/or scarring (especially to their face)
- Frightened by shortness of breath and trouble swallowing
- Some interpreted side effects to be specific to their eyes (e.g., burning, irritation, itching) and worried about eyesight
- Worried about light sensitivity impacting their ability to be outdoors
- Found side effects to be similar to cancer treatment
- Wanted to see tangible evidence of effectiveness
Prophylactic Surgery - Viewed as a “last resort”
- Needed to be at high risk in order to consider
- Concerned about surgical complications and recovery time
- Expressed hesitation (especially 30–45 year olds) due to desire to have children and breastfeed
- Worried about impact on hormones and sexual pleasure
- Noted emotional impact of a mastectomy, but found benefit in being able to consider reconstructive surgery
- Expected significant reduction and/or elimination of cancer